Saturday, November 07, 2009

MedWire News - Diabetes - FDA to revise prescribing information for exenatide, sitagliptin

Posted via web from Jack's posterous

1 comment:

Randeg said...

This was described under gossip but I think it is important information for the diabetics. They can then consult with their doctor and be reassured that they are on the right track or if they need to have their prescription changed. Information like this is crucial to any prescription revision.

Evelyn Guzman
http://www.free-symptoms-of-diabetes-alert.com (If you want to visit, just click but if it doesn’t work, copy and paste it onto your browser.)